4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-028132
Chief Development Officer sold 1,385 shares at $15.01 ($20,789)
- Chief Development Officer acquired 1,385 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Development Officer | 2022-08-08 | Option exercise | +1,385 | $4.30 | $5,956 | 54,416 | D |
| Michaelson Jennifer Chief Development Officer | 2022-08-08 | Sale | −1,385 | $15.01 | $20,789 | 53,031 | D |
| Derivatives | |||||||
| Michaelson Jennifer Chief Development Officer | 2022-08-08 | Option exercise · Stock Option (Right to Buy) | −1,385 | 208,593 | D | ||
| Open-market sales · 1,385 sh · avg $15.01 · $20,789 | |||||||
Loading xslF345X03/doc4.xml…